Studies in people and animal models suggest that depression is influenced by natural fluctuations in the levels of 17β-oestradiol (E 2 ), as well as administration of E 2 -based therapies, such as selective oestrogen receptor modulators (SERMs). Elucidating the effects and mechanisms of E 2 is important to improve future E 2 -based therapeutics. An important question is whether effects of E 2 or SERMs for mood regulation act at the α or β isoform of the oestrogen receptor (ER) because some of the unwanted trophic effects of E 2 -based therapies may involve actions at ERα, rather than ERβ. In the present study, whether there are sex differences in depression-like behaviour of adult mice (experiment 1), and the effects of natural fluctuations in E 2 (experiment 2), or administration of E 2 or a SERM that has higher affinity for ERβ than for ERα (diarylpropionitrile; DPN) to ovariectomised (experiment 3) wildtype and ERβ knockout (βERKO) mice were investigated. Results of this study supported our hypotheses that: there would be sex differences favouring males for depression-like behaviour and endogenous increases in, or exogenous administration of, E 2 or administration of an ERβ SERM would decrease depression-like behaviour in wildtype, but not βERKO, mice. In experiment 1, adult male mice spent less time immobile in the forced swim test (i.e., showed less depression-like behaviour) compared with female mice. In experiment 2, pro-oestrous (higher circulating E 2 levels), compared with dioestrous (lower circulating E 2 levels), mice had reduced immobility in the forced swim test; this effect was not observed in βERKO mice. In experiment 3, administration of E 2 or DPN to ovariectomised wildtype, but not βERKO, mice decreased immobility compared with vehicle administration, these data suggest that ERβ may be required for some of the anti-depressant-like effects of E 2 .
Introduction
Sex differences in incidence and severity of depression disorders suggest that women may be more vulnerable than men. Women are twice as likely to be diagnosed with major depres-sion disorders, such as unipolar depression, compared with men (Earls, 1987; Kessler, et al., 1993; Nolen-Hoeksema, 1987) . There are longer and more frequent episodes of depression among women than among men who have been diagnosed with a depression disorder (Earls, 1987; Nolen-Hoeksema, 1987) . There are similar sex differences reported in animal models of depression. Compared with male rats, female rats have increased immobility in the forced swim test animal model of depression-like behaviour (Frye and Wawrzycki, 2003) . However, there are some inconsistencies reported in the pattern of sex differences in the forced swim test of rats and mice when differences related to oestrous cycle, stressor exposure, gene knockout, central lesions and/or treatment with compounds that may have anti-depressant actions, are taken into account (Akanmu, et al., 2007; Barros and Ferigolo, 1998; Bhatnagar, et al., 2004; Bielajew, et al., 2003; Brotto, et al., 2000; Consoli, et al., 2005; Contreras, et al., 1995; Marvan, et al., 1996) . For example, gestational stress or chronic mild stress exposure increases immobility in the forced swim test or decreases sucrose consumption (which is considered one index of anhedonia in rodents) of female, but not, male rodents (Alonso, et al., 2000; Dalla, et al., 2005) . In another animal model of depression-induction, the novel open space swim test, female rats expressed a depression-like phenotype more readily than males (Sun and Alkon, 2006) . Although the timing of this sex difference in animal models is not clearly reported in the literature, among people, sex differences in depression occur post-puberty, suggesting a role of ovarian steroids, such as 17β-E 2 (E 2 ), in depression (Seeman, 1997; Young, 1998; Young and Altemus, 2004; Young and Korszun, 2002) . At puberty, females begin secreting E 2 from their ovaries in a cyclical pattern, whereas E 2 levels among males is typically very low. As such, these data suggest that some of these postpubertal sex differences in depression are not because of absolute levels of E 2 , but they may be related to responses to fluctuations in E 2 as has been shown among some women (Schmidt, et al., 1998) . Indeed, sex differences in depressionlike behaviour of rodents are more evident when endogenous changes in E 2 levels are considered.
Endogenous changes in E 2 alter depression behaviour. Some of the most convincing evidence that fluctuations in E 2 levels may underlie the increased propensity for some women to develop neuropsychiatric disorders with depressive symptoms is that there is an increase in these disorders coincident with substantial fluctuations in E 2 , such as that occuring in premenstrual, postpartum and peri-and post-menopausal women (Bebbington, et al., 1981; reviewed in Bloch, et al., 2003; Jenkins, 1987; reviewed in Rubinow and Schmidt, 1995; Weissman and Klerman, 1977) . Furthermore, women with postpartum depression or premenstrual syndrome, compared with those who have not been diagnosed with these disorders, respond favourably to gonadotropin-releasing hormone agonists, which stabilise E 2 levels (Bloch, et al., 2000; Schmidt, et al., 1998) . Evident in animal models are the effects of endogenous increases in E 2 levels to alter depression-like behaviour. Prooestrous or pregnant rats with acute and chronic elevations in E 2 , respectively, show less depressive behaviour in the forced swim test than rats with lower E 2 levels, such as dioestrous, post-partum or male rats Walf, 2002, 2004) . Additionally, depressive behaviour in the differential reinforcement model of depression is increased among rats three days postparturition, a time characterised with lower and/or fluctuating levels of E 2 (Molina-Hernández, et al., 2000) . There are also oestrous cycle phase-dependent effects of inescapable shock to enhance, and clomipramine to attenuate, depression behaviour in the forced swim task of female rats (Marvan, et al., 1996 (Marvan, et al., , 1997 . Notably, cyclical changes in E 2 throughout the lifespan of women and female rodents cannot be separated from the effects of co-varying progestins. Thus, it is important to investigate effects of natural fluctuations in E 2 and effects of E 2 replacement.
Administration of E 2 to females with low endogenous E 2 levels decreases depression behaviour, but this effect may depend upon many factors, such as individual differences in sensitivity to E 2 , E 2 regimen utilised and/or individual history. In support, in two double-blind, placebo-controlled studies of E 2 replacement to perimenopausal women, baseline E 2 levels or those produced by E 2 therapy, did not predict a favourable response to E 2 for mood scores Soares, et al., 2001) . Furthermore, oral-conjugated E 2 therapy, compared with placebo, improved ratings on the Hamilton Scale of Depression of severely depressed pre-and post-menopausal women; however, this favourable response to E 2 varied as a function of depression duration (i.e., was greater among women with a shorter history of depression; Klaiber, et al., 1979) . Reports from the literature also support the notion that E 2 regimen utilised contributes to its efficacy (Gregoire, et al., 1996; Saletu, et al., 1995) . Indeed, negligible findings for E 2 to improve mood of older women in the Women's Health Initiative studies (who were many years postmenopausal) further support the idea that response to E 2 may be sensitive to all of these factors (Brunner, et al., 2005; Hays, et al., 2003; Smoller, et al., 2003) . Despite these findings, some studies show a beneficial effect of E 2 for mood in perimenopausal, and to a much lesser extent postmenopausal, women (Cohen, et al., 2003; Ditkoff, et al., 1991; Heinrich and Wolf, 2005; Morrison, et al., 2004; Rausch and Parry, 1993; Schmidt, et al., 2000; Sherwin, 1991; Sherwin and Gelfand, 1985; Soares, et al., 2001; Zweifel and O'Brien, 1997) . Indeed, the most consistent positive effects of E 2 to improve mood are observed in perimenopausal, depressed women who were administered transdermal E 2 . Given some of these limitations in clinical studies, evidence of the effects of E 2 from animal models may be particularly informative. Among rodents, ovariectomy (ovx), the surgical removal of the primary endogenous source of E 2 , can be used as an animal model of menopause in which individual differences related to age, life history, length of ovarian cessation and E 2 dosing/regimen are experimentally controlled. Ovx mice or rats have increased depressive-like behaviour compared with hormone-replete counterparts (Bekku, et al., 2006; Galea, et al., 2001; Stoffel and Craft, 2004) , and these effects are sustained throughout the period of endogenous hormone deprivation (Bekku and Yoshimura, 2005) . Furthermore, the effects of fluoxetine to reduce depressive behaviour in the forced swim test are attenuated by ovx (Estrada-Camarena, et al., 2004 . In a genetic model of depression, the Flinders Sensitive Line, a lower expression of 5-HT 2A was reversed by E 2 administration (Osterlund, et al., 1999) .
Administration of E 2 to ovx rodents can produce anti-depressant-like effects (Bernardi, et al., 1989; Estrada-Camarena, et al., 2003; Frye and Wawrzycki, 2003; Hilakivi-Clarke, 1996; Okada, et al., 1997; Rachman, et al., 1998; Walf and Frye, 2005; Walf, et al., 2004) . This effect is doseresponsive, such that anti-depressant-like effects are observed following administration of E 2 that produces pro-oestrous-like, and not higher or lower, E 2 levels (Walf and Frye, 2005) . Despite this indication that E 2 can have clear anti-depressantlike effects, another important issue that is related to efficacy of E 2 -based therapies is E 2 's targets and mechanisms of action.
A likely target for E 2 's anti-depressant-like effects is oestrogen receptors (ERs), of which there are two identified types (i.e., ERα and ERβ). In support, intra-hippocampal administration of an ER antagonist attenuates anti-depressive-like behaviour of pro-oestrous rats (Walf and Frye, 2006) . More recent investigations suggest that this effect may be related to ERβ activity. For instance, rendering ERβ inactive via intracerebroventricular administration of antisense oligonucleotides decrease ERβ expression in the hippocampus and obviates the anti-depressive-like effects of E 2 administration to ovx rats . Activating ERβ with administration of ERβ agonists (i.e., selective oestrogen receptor modulators -SERMs), such as diarylpropionitrile (DPN) or coumestrol, produces similar effects as E 2 (which has equal affinity for ERα and ERβ) to decrease depressive-like behaviour of ovx rats . A similar effect is observed when E 2 , DPN or coumestrol are administered directly to the hippocampus, a limbic brain region that predominantly expresses ERβ (Shughrue, et al., 1997 (Shughrue, et al., , 1998 Walf and Frye, 2007) . Indeed, differential distribution of these receptor types, as well as determining whether E 2 has actions via ERα and ERβ, is important and relevant because of the potential for negative side-effects associated with E 2 therapies, such as increased risk for certain cancers. E 2 's proliferative effects are likely via its binding to ERα, which is predominant in mammary and uterine tissue (as reviewed in Gustafsson, 2003) . ERβ is more widely distributed in the limbic regions of the brain and in bone, which may underlie some of the beneficial effects related to mood and/or osteoporosis treatment associated with this receptor subtype (Gustafsson, 2003; Shughrue, et al., 1997 Shughrue, et al., , 1998 . Furthermore, it has been suggested that increases in ERβ expression may be associated with increased survival in breast cancer patients (Gruvberger-Saal, et al., 2007; Lin, et al., 2007) . As such, it is critical to elucidate the mechanisms of E 2 for its favourable effects.
To begin to investigate the role and mechanisms of E 2 for depression-like behaviour, the following experimental series was conducted using the forced swim test animal model of depression. In experiment 1, evidence for sex differences in the forced swim test performance of mice was determined by comparing duration of immobility of intact, adult male and female mice. In experiment 2, the requirement of ERβ for the effects of endogenous fluctuations in E 2 for duration of immobility was determined by comparing pro-oestrous and dioestrous mice that were wildtype (WT) or ERβ knockouts (βERKO). In experiment 3, the requirement of ERβ for the effects of SERMs (E 2 or DPN) to ovx WT and βERKO mice to alter immobility in the forced swim test was compared with administration of vehicle to WT and βERKO mice. We hypothesized that if there are sex differences in depression-like behaviour, and if these are due to effects of E 2 and its actions involving ERβ, then, in general: 1) Female mice would have increased immobility compared with male mice. 2) When oestrous cycle is taken into account, pro-oestrous mice would have decreased depression-like behaviour compared with dioestrous mice, and this effect would only be evident in WT, but not βERKO, mice. 3) E 2 or DPN administration to ovx WT, but not βERKO, mice would produce anti-depressant-like effects.
Materials and methods
All methods used were pre-approved by the Institutional Animal Care and Use Committee at University at Albany -State University of New York, Albany, New York, USA.
Animals and housing
Subjects (N = 151) were adult (8 to 10-week old) female (n = 141) or male (n = 10) mice. Mice were group-housed by sex (4-5/cage) in polycarbonate cages (26 × 16 × 12.5 cm 3 ), containing woodchip shavings for bedding, in a temperaturecontrolled room (21 ± 1°C) in the Laboratory Animal Care Facility. Mice were maintained on a 12/12-h reversed light cycle (lights off at 8:00 a.m.) with Purina Mice Chow (Purina, St. Louis, MO, USA) and tap water in their home cages ad libitum.
Mouse strain and genotyping
All experimental mice were bred in our colony in the Laboratory Animal Care Facility (original breeder pairs on a C57BL/6 background were from Jackson Laboratories, Bar Harbor, Maine, USA). There are no phenotypic characteristics that can be used to determine whether experimental mice were WT or heterozygous or homozygous for the ERβ gene knockout. Genotypes of experimental mice were determined with polymerase chain reaction (PCR). PCR was conducted using tails collected from experimental mice, isolating genomic DNA from these tails and running a typical PCR analyses as per the Jackson Laboratory protocol for this strain. In brief, DNA was denatured at 94°C for 3 min, followed by 35 cycles of amplification: 94°C for 30 s, 60°C for 30 s, 72°C for 30 s and a final primer extension step at 72°C for 2 min. Specific primers (obtained from Integrated DNA Technologies; Coralville, Illinois, USA) were used: ESR2-1, which lies upstream of insertion site in exon 2 (5′-GTTGTGCCAGCCCTGTTACT-3′), ESR2-1, which lies downstream of the insertion site in exon 2 (5′-TCACAGGACCAGACACCGTA-3′) and ESR2-3, a neo gene-specific primer (5′-GCAGCCTCTGTTCCACATACAC-3′). Bands of approximately 106 and 160 bp were amplified for WT (n = 80) and homozygous βERKO (n = 71) mice, respectively. PCR was done in the laboratory of Dr Anne Messer at The Wadsworth Center (Albany, New York, USA), the Molecular Core Facility at the University of Albany or in our laboratory at the University of Albany, Albany, New York, USA.
Determination of oestrous cycle
In experiment 2, mice were removed from their housing room and transported on a cart in their home cages to the adjacent core behavioural testing facility between 7:00 and 9:00 a.m. daily. Vaginal epithelium of experimental mice was obtained by lavage and examined under a light microscope daily. After 2 weeks of regular, 4-5 day cycles, mice were tested when in pro-oestrus or diestrus. Mice were considered to be in prooestrus when their vaginal smears had characteristic nucleated cells, 4-5 days following the previous smear of this type. Mice in diestrus had a heterogeneous cell type in their vaginal smears for two consecutive days, and nucleated cells were not evident.
Ovariectomy
In experiment 3, mice were ovx under sodium pentobarbital anaesthesia (80 mg/kg; i.p.). In brief, an incision was first made in the skin and then in the abdominal wall. The ovary, oviduct and top of the fallopian tube were ligated and removed. The abdominal wall was sutured. The skin was closed with surgical adhesive and/or wound clips. After full recovery from anaesthesia, mice were returned to grouphousing in their home cages.
Hormone administration
In experiment 3, ovx mice were administered vegetable oil vehicle (0.2 cm 3 ), E 2 (0.1 mg/kg; Steraloids, Newport, Rhode Island, USA) or DPN (0.1 mg/kg; Tocris, Ellisville, Missouri, USA). Compounds were dissolved in vegetable oil and administered via subcutaneous injections in the scruff of the neck 44 h before behavioural testing.
Screening/handling procedure Before behavioural testing, mice were evaluated for their general health and normative responses to stimuli (as modified from Crawley, et al., 2007; and described in Frye and Walf, 2008) . Briefly, health status of mice (based upon appearance of clean fur, whiskers, posture, gait, muscle tone and normative behaviour, such as presence of fur grooming, building nests with Nestlet squares provided in home cage, huddling with cage mates, ability to cage climb, paw withdrawal) was determined. Additionally, whether there were normative sensory responses (i.e., a blink or twitch reflex to a cotton swab placed close to their eyes or ears, respec-tively). In this study, mice did not differ based upon genotype for health status or reflex measure.
To habituate mice to steroid injections, handling by the investigator, and behavioural testing, mice were first subjected to a habituation/handling protocol. The protocol used was one modified from published methods . Mice were picked up from their home cage, handled for 15 s and returned to their home cage (Day 1). Mice were then transferred from their home cage to a novel cage (Day 2) and weighed and then returned to their home cage (Day 3). On Day 4, mice were transferred to another room via a cart. On Day 5, they were transferred to another room via a cart, injected with 0.2 cm 3 vegetable oil subcutaneously and placed in novel environment for 5 min.
Experimental procedure
In this study, mice were tested on one occasion in the forced swim test. Mice that were to be tested on a given day were then individually housed immediately before testing and returned to their home cages following testing. Behavioural data were collected by trained observers and simultaneously video-recorded with a video-tracking system (Any-maze-Stoelting, Inc., Wood Dale, Illinois, USA). In experiment 1, adult, gonadally-intact male (n = 10) and female (n = 10) mice were tested in the forced swim task. In experiment 2, mice were cycled daily and tested in pro-oestrus (WT: 8; βERKO: 12) or diestrus (WT: 9; βERKO: 11). In experiment 3, mice were randomly assigned to be administered vegetable oil vehicle (WT: 17; βERKO: 18), E 2 (WT: 12; βERKO: 13) or DPN (WT: 14; βERKO: 17).
Forced swim test
The forced swim test is a commonly used bioassay to investigate depressive behaviour of mice and a screening tool for antidepressants (Barros and Ferigolo, 1998; Petit-Demouliere, et al., 2005) . In the forced swim test, the dependent measure of depression-like behaviour is time spent immobile. Immobility is quantifiable and readily identifiable as the absence of active behaviours (i.e., swimming, jumping or diving) following placement in the testing chamber (Porsolt, et al., 1977) . The protocol in our lab for the forced swim test was used as per previous descriptions . Briefly, mice were placed in a glass cylinder, which was 20.5 cm in diameter and 21.5 cm in depth, and was filled with 18 cm of 25°C water. The time spent immobile was simultaneously recorded by the video-tracking system and an experimenter, who was blind to the treatment of mice and/or the hypothesized outcome of the study.
Statistical analyses
In experiment 1, a one-way analyses of variance test (ANOVA) was used to determine effects of sex for time spent immobile in the forced swim test. In experiment 2 and 3, two-way ANOVAs were used to determine effects of hormone condition and genotype (WT vs βERKO) for time spent immobile. As appropriate, group differences were determined by Fisher's post-hoc tests. In the case of significant interactions, main effects for these measures are not described. A P value of ≤0.05 was considered significant.
Results
Male mice have decreased depressive behaviour compared with female mice (Figure 1) There was a significant effect of sex for time spent immobile in the forced swim test [F(1,18) = 4.86, P < 0.04]. Female mice spent more time immobile than did male mice.
Pro-oestrous WT, but not βERKO, mice have decreased depressive behaviour compared with dioestrous mice (Figure 2) There was a significant interaction between oestrous cycle phase and genotype [F(1,36) = 4.07, P < 0.05]. This was due to pro-oestrous WT, but not βERKO mice, spending less time immobile in the forced swim test compared with dioestrous mice.
SERMs decrease depressive-like behaviour of WT, but not βERKO, mice (Figure 3) There was a significant interaction between genotype and SERM condition [F(2,85) = 6.70, P < 0.01] in ovx mice. This was due to E 2 or DPN, compared with vehicle, administration to ovx WT, but not βERKO, mice decreasing time spent immobile.
Discussion
The results of the present study supported our hypothesis that sex differences in depression-like behaviour may be due to effects of E 2 and its actions involving ERβ. First, gonadally intact female mice showed more depressive-like behaviour than did male mice in the forced swim test. Second, mice in pro-oestrus had decreased immobility in the forced swim test compared with dioestrous mice; these effects were obviated in βERKO mice. Third, ovx WT mice that were administered E 2 or DPN spent less time immobile than mice that were administered vehicle; E 2 or DPN did not decrease immobility, compared with vehicle, when administered to ovx βERKO mice. Together, these data suggest that ERβ is required for E 2 's anti-depressant-like effects.
The present data confirm and extend the literature supporting the existence of sex differences for depression behaviour in rodents. Although not all studies show a clear sex difference in depression-like behaviour in animal models, and few studies have investigated this question in mice, the present study confirmed published findings that female rats show more depression-like behaviour than males (Frye and Wawrzycki, 2003) . Indeed, some differences may be due to stressor exposure. In our forced swim test paradigm, mice are exposed to the chamber once, eliminating any effects of habituation to this task, which likely produces a greater response given its novelty. Indeed, in the studies that report clear sex differences favouring males, stressor exposure was a typical method to induce depression-like behaviour (Alonso, et al., 2000; Dalla, et al., 2005; Sun and Alkon, 2006) . Depression is considered a neuropsychiatric disorder that is mediated, in part, by the hypothalamic-pituitary-adrenal axis (HPA) and likely involves modulation by steroids of the hypothalamic-pituitary-gonadal axis (HPG; Young, 1998; Young and Korszun, 2002; Young, et al., 2000 Young, et al., , 2007 . For example, females may be particularly sensitive to the effects of stress. As one example, gestational stress produces greater loss in hippocampal cells among females compared with their male rat counterparts (Schmitz, et al., 2002) . Another consideration to make is that, in addition to the role of the HPA, HPG steroids produce robust effects on affective behaviour of rodents, which may mask the role of sex differences for these behaviours. In Experiment 1, we did not take into consideration what oestrous cycle phase female mice were in when they were tested. However, this was investigated in Experiment 2. We found that, as has been reported in rats, pro-oestrous mice show less depressive behaviour in the forced swim test than do dioestrous mice (Frye and Walf, 2002) . As an extension to these data, we found that this oestrous cycle effect only occurred in WT mice with functional ERβ, and not in their βERKO counterparts. These data suggest that ERβ may be an important target for the pro-oestrousassociated decreases in depression-like behaviour.
The present results that administration of E 2 or the ERβ agonist, DPN, decreased depression-like behaviour confirm and extend previous findings showing the anti-depressant-like effects of E 2 or SERMs. In support, subcutaneous administration of E 2 or raloxifene, a SERM that is typically prescribed to menopausal women for treatment of osteoporosis, similarly decrease immobility in the forced swim test when administered to aged female mice (Walf and Frye, 2006) . Subcutaneous administration of E 2 or SERMs that have greater affinity for ERβ than ERα similarly decrease immobility in the forced swim test of young adult ovx rats . In the present study, E 2 and DPN similarly decreased immobility when administered to WT mice; however, the antidepressant-like effects of these compounds were not observed among mice lacking ERβ. In fact, βERKO mice had increased immobility (i.e., greater depressive-like behaviour) compared with their WT counterparts, which is consistent with previous reports using the forced swim test (Rocha, et al., 2005) . Furthermore, temporary knockdown of ERβ, which was relegated to duration of E 2 priming, of ovx rats increased immobility in the forced swim test . Indeed, the results from the present study provide some evidence that the effects of E 2 or SERMs in mice for affective behaviour are not solely because of the gross motor changes that E 2 can promote (Becker, et al., 1987; Joyce and Van Hartesveldt, 1984; Pfaff, 2001, 2002) . It is notable that the beneficial effects of E 2 and SERMs in this animal model reflect a decrease in motor behaviour, rather than an increase in motor behaviour, which is typical in anxiety measures, such as the elevated plus maze or open field. Together, these data confirm that beneficial effects of E 2 can be observed in young and aged mice and that ERβ may be required for these effects.
In summary, the results of the present study supported the notion that ERβ is an important target for the effects of E 2 for depression behaviour. Sex differences were observed, favouring males, in the forced swim test. Mice in pro-oestrus had decreased immobility in the forced swim test, compared with dioestrous mice, and these oestrous cycle effects did not occur in βERKO mice. Lastly, ovx WT, but not βERKO, mice that were administered E 2 or the ERβ SERM, DPN, spent less time immobile than mice that were administered vehicle. These data suggest that sex-and hormone-dependent effects on depressionlike behaviour in the forced swim test can be measured reliably in mice and that ERβ may be required for E 2 's anti-depressantlike effects. This study has clinical relevance given that, although there is some evidence for favourable effects of E 2 on mood (and other symptoms associated with cessation in E 2 secretion during menopause, such as osteoporosis, hot flashes, vaginal dryness, cognitive deficits) among women, there are controversies regarding the magnitude of this effect. In addition, whether these beneficial effects can occur independently of the proliferative effects E 2 can have in E 2 -sensitive organs, which can increase risk of cancer in breast and/or uterine tissue is also of great concern. Indeed, although the present data suggest a role of E 2 via ERβ for anti-depressant-like effects, investigating the targets of E 2 for its functional effects needs further investigation.
